Introducing Prequel with AMPLIFY Technology. Demonstrated accuracy across all types of patients with our noninvasive prenatal screen.
The Myriad Prequel Prenatal Screen is designed to provide individualized analysis and support for each patient, so you can seamlessly incorporate prenatal genetic screening into your practice. This means more of your patients will benefit from valuable information that can make a difference in health outcomes for families.
Prequel’s clinical experience study demonstrates that high sensitivity and specificity can be achieved, without having to fail samples to do so.3
Prequel delivers results to 99.9% of patients.3
Patients receive a highly, accurate result early in pregnancy regardless of body habitus, race or ethnicity, reducing patient anxiety and the risk associated with unnecessary invasive procedures.3, 4
A primary focus on common aneuploidies, as recommended by societal guidelines1,2 with options for additional screening
Analyzes all 22 numbered chromosome pairs to provide additional insights into the health of the pregnancy
Clarity of your patients’ true risk with individualized positive predictive values (PPV) and residual risk estimates to help inform next steps
Watch this patient story to hear how noninvasive prenatal screening can give a patient like Hannah, early insights into her pregnancy to help prepare her family.
The Myriad Prequel Prenatal Screen is a noninvasive prenatal screen that uses cell-free DNA (cfDNA) to determine if a pregnancy is at an increased risk for common chromosome abnormalities, such as Down syndrome.
cfDNA screening has been shown to be superior to methods that use maternal age, ultrasound, and serum screening. This results in a lower false-positive rate and false-negative rate.5
The Prequel Prenatal Screen can be ordered together with the Foresight® Carrier Screen and offered to all women, including those with high BMI, an ovum donor or a twin pregnancy. Prequel can now provide individual fetal sex information for twins, in addition to singletons.
Common aneuploidies: Trisomy 21, Trisomy 18, Trisomy 13.Optional analysis of sex chromosomes (which includes the ability to determine fetal sex for singletons and twins), microdeletions, and expanded aneuploidies.
All pregnant women
As early as 10 weeks into pregnancy
One tube of blood
Results in ~ 1 week
We provide resources to help educate your patients about Myriad products.
We offer a comprehensive program to make genetic products accessible for more of your patients.
We deliver screening and testing results effectively and thoroughly so you can focus on care plans.
We provide consults from patient educators, who are genetic counselors, tailored to help address any questions your patients may have.